NCT00756509 2026-01-20
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Novartis
Phase 4 Completed
Novartis
Massachusetts General Hospital
Institut National de la Santé Et de la Recherche Médicale, France